Syquant Capital SAS’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Syquant Capital SAS’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,587	Closed	-$2M	–	22
2019 Q3	$2M	Buy	20,587 +1,000	+5%	+$100K	0.55%	12
2019 Q2	$2M	Sell	19,587 -538,937	-96%	-$58.2M	0.64%	10
2019 Q1	$63.6M	Buy	+558,524	New	+$41.1M	24.61%	1

Syquant Capital SAS's ONCE Position: Q4 2019 in Review

Syquant Capital SAS sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 20,587 shares — an estimated $2M sold.

Syquant Capital SAS first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $63.6M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Syquant Capital SAS reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Syquant Capital SAS sold 20,587 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2M.
Syquant Capital SAS first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Syquant Capital SAS's Spark Therapeutics, Inc. Common Stock position peaked at $63.6M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Syquant Capital SAS's 13F filing for Q4 2019, filed 8 Jan 2020.